PRMT2 has been found to play a “dual role” in colorectal cancer (CRC): it intrinsically promotes tumor stemness and metastasis by activating the WNT5A/β-catenin signaling pathway and extrinsically regulates the TIME. This evidence concerns the gene PRMT2 and neoplasm.